Michael Moore - 18 Jan 2022 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Jan 2022, 16:37:54 UTC
Prior SEC filing
10 May 2021
Next SEC filing
10 May 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Moore

Key filing fact

Michael Moore filed Form 4 for VIEMED HEALTHCARE, INC. (VMD) on 20 Jan 2022.

Key facts

  • This page summarizes Michael Moore's Form 4 filing for VIEMED HEALTHCARE, INC. (VMD).
  • 3 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 20 Jan 2022, 16:37.

Change

  • Previous filing in this sequence was filed on 10 May 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VMD transaction Derivative

Stock Options

Award

Transaction value
$0
Shares
+85,410
Change %
Price
$0.000000
Shares after
85,410
Date
18 Jan 2022
Ownership
Direct
Underlying class
Common Shares
Underlying amount
85,410
Exercise price
$5.21
Footnotes
F1
VMD transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+56,937
Change %
Price
$0.000000
Shares after
56,937
Date
18 Jan 2022
Ownership
Direct
Underlying class
Common Shares
Underlying amount
56,937
Exercise price
Footnotes
F2, F3
VMD transaction Derivative

Phantom Share Units

Award

Transaction value
$0
Shares
+28,468
Change %
Price
$0.000000
Shares after
28,468
Date
18 Jan 2022
Ownership
Direct
Underlying class
Common Shares
Underlying amount
28,468
Exercise price
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Options granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date.

Footnote F2

Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

Footnote F3

Restricted Stock Units granted to reporting person on January 18, 2022, which vest in three equal installments beginning on the first anniversary of the grant date.

Footnote F4

Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.

Footnote F5

Represents an award granted in 2022 under the Issuer's Phantom Share Unit Plan which vests in equal installments on January 18, 2023, January 18, 2024, and January 18, 2025, subject to the Reporting Person's continued employment with the Issuer on such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .